Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SoFEA: Fulvestrant +/- Anastrozole vs Exemestane in Advanced Breast Cancer
NCT00253422Phase 3Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Mar 2004
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fulvestrant in breast cancer, sponsored by The Institute of Cancer Research. Started Mar 2004; status: completed.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00253422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253422.